Connect with us

News Wire

Onco.com launches Cancer Care App for Cancer Management

BANGALORE, India, April 9, 2021 /PRNewswire/ — Onco.com, one of India’s leading online cancer care platform, launched the world’s first cancer care app aimed at helping cancer patients and caregivers avail various services through their phone. The app, Onco Cancer Care, allows patients and caregivers to book and manage their appointments and treatments, and also chat with their care manager for any queries.

Cancer patients can now completely manage their treatment journey through the app. They can book online and in-person consultations with top oncologists across the country. They can also book diagnostic tests and avail an online opinion from a panel of experienced oncologists. 

The app intends to reduce the waiting time for patients at hospitals and clinics by allowing them to make online payments for consultations and treatment. They will also get additional benefits via discounts and cashback, which can be utilised while making payment for future services. 

Speaking about the new app, Rashie Jain, CEO and Co-founder of Onco.com, said, “We are excited to announce the launch of the world’s first care management app for cancer. Onco.com has been a pioneer in providing end-to-end care management services to cancer patients and now these services will also be made available on the app. Through the chat feature of the app, cancer patients can communicate with their care managers anytime of the day and get real-time guidance on their concerns. The app also allows users to share their test reports or other medical documents with the care manager to receive a comprehensive opinion from a panel of expert oncologists from across India and the US. The launch brings us a step closer to our patients and strengthens our vision towards becoming their trusted partner in their treatment journey. The app is currently available for download on both Google Play Store and App Store.”

Dr Amit Jotwani, Co-founder and Chief Medical Officer, Onco.com, said, “Every cancer journey is tough, and it requires more than doctors and hospitals to sail through safely and successfully. Cancer patients struggle with unresolved questions and concerns about their condition on a daily basis, while they get only a few minutes with their treating doctors once in a few weeks. The Onco Cancer Care app helps them get real-time personalized answers including report interpretations, side effects support, medical second opinions etc, on a continuous basis, through uninterrupted medical, nutritional and psychological support all along the treatment journey, from the comfort of their homes.”

The burden of cancer is increasing globally, and in India, an estimated 1.45 million new cases of cancer were diagnosed in 2019 alone. Online healthcare has seen a massive growth owing to the pressing demand for digital access to doctors and medical services during the COVID-19 pandemic, particularly for cancer patients, for whom delays in treatment can have severe consequences. 

The company plans to add video call consultation over the app, making it easier for patients to discuss their case and treatment with the oncologist. Also a content and community section will feature on the app in future. This is to provide useful tips to patients on post-treatment care, and also to connect cancer patients with survivors who have been through a similar experience. 

One can download the app here

For any queries related to cancer treatment, one can contact a care manager from Onco.com on 79965 79965 or can visit https://onco.com/.

About Onco.com:

Onco.com is an online cancer platform offering cutting edge treatment advice and care management to cancer patients. Through its network of 1500+ oncologists, 500+ hospitals and labs, Onco.com allows cancer patients to get personalized advice and embark on their treatment journey with more confidence.

In addition to the ‘Call Onco’ service, which allows cancer patients and caregivers to teleconsult with top oncologists, Onco.com also offers the following services:

  • Onco Tumor Board: This opinion is offered in the form of a report and comprises advice from a multi-disciplinary panel of oncologists (usually 2-3 specialists). The report is an exhaustive review of the patient’s condition and offers cutting-edge scientific treatment advice as well as answers to specific questions that the patient or their family may have. Patients can get this opinion from Indian as well as US-based oncologists who are carefully chosen experts in specific cancer types.
  • Onco Connect: Onco.com also books priority appointments at discounted prices with relevant senior oncologists, treatment centers, and diagnostic labs with standard accreditations to ensure the best quality of care.
  • Onco Care Management: Every patient gets lifelong care management support where they are mapped to a care manager who helps them navigate through their treatment journey with ease. Patients have access to Onco.com’s care team as well as oncologists and have access to information and the right advice at every step. This is a subscription service that is currently offered for free.

Logo: https://oyefilmy.com/wp-content/uploads/2021/04/onco-com-launches-cancer-care-app-for-cancer-management-1.jpg  

 

Continue Reading
Advertisement
Click to comment

You must be logged in to post a comment Login

Leave a Reply

News Wire

Reliance Digital Introduces High-Performance iQOO 15R to its Nationwide Store Network

MUMBAI, India, March 11, 2026 /PRNewswire/ — Reliance Digital announces the offline retail availability of iQOO, the high-performance smartphone brand built for today’s youth and tech-forward consumers. Following strong traction in online channels, iQOO is now extending its presence into physical retail, allowing customers to experience and purchase its devices first-hand at Reliance Digital stores across India.

Known for pushing the boundaries of speed, and power, the iQOO 15R is powered by the Snapdragon 8 Gen 5, delivering exceptional speed, responsiveness, and sustained performance throughout the day. It packs iQOO’s biggest battery yet in an ultra-slim 7.90mm design, making it India’s slimmest smartphone with a 7600 mAh battery.

The device features a 6.5K IceCore VC Cooling Chamber for stable performance and runs on OriginOS 6.0 based on Android 16 out of the box, supported by 4 years of software updates and 6 years of security updates. It is also equipped with a Sony LYT-700V OIS camera, a 1.5K 144Hz AMOLED EyeCare display, and IP68 & IP69 dust and water resistance, making it a dependable daily partner for professionals on the go.

The brand’s offline expansion marks an important step in deepening consumer engagement by offering hands-on access to its devices, enabling customers to explore iQOO’s powerful performance, advanced display technology, and flagship-grade camera capabilities in a real-world retail environment.

The availability of iQOO at Reliance Digital brings together two brands driven by innovation and consumer experience. While iQOO continues to build its reputation as a performance-led smartphone brand, Reliance Digital strengthens its portfolio by offering customers access to cutting-edge technology brands through its extensive nationwide retail network.

Through engaging in-store experiences, knowledgeable staff, and immersive product demonstrations, Reliance Digital aims to help consumers better understand iQOO’s performance-first DNA. This move further reinforces Reliance Digital’s commitment to staying ahead of evolving consumer preferences and serving as a preferred destination for discovering new-age technology.

With this expansion, Reliance Digital continues to play a key role in shaping India’s consumer electronics landscape by bringing future-ready brands closer to customers, while enabling smartphone brands like iQOO to build stronger connections with a growing, performance-driven audience.

The all new iQOO 15R is now available at Reliance Digital stores nationwide.

Photo: https://oyefilmy.com/wp-content/uploads/2026/03/reliance-digital-introduces-high-performance-iqoo-15r-to-its-nationwide-store-network-1.jpg

 

Cision View original content to download multimedia:https://www.prnewswire.com/in/news-releases/reliance-digital-introduces-high-performance-iqoo-15r-to-its-nationwide-store-network-302711079.html

Continue Reading

News Wire

Kotak Alts announces winner of the inaugural Katalyst Awards

Ms Himani Choudhary named Katalyst for the year – India’s Best Financial Content Creator; wins Rs. 25 Lakhs

MUMBAI, India, March 10, 2026 /PRNewswire/ — Kotak Katalyst Awards, a national initiative instituted to recognise excellence and responsibility in financial content creation has announced the winner of its first Katalyst edition. Kotak Alternate Asset Managers Limited (“Kotak Alts”) today announced Himani Choudhary as the winner. The winner was awarded a prize of INR 25 Lakhs, positioning Katalyst among the most meaningful recognitions for financial content creators in India.

Srini Sriniwasan, Managing Director, Kotak Alts, said, “The Kotak Alts Katalyst Awards were instituted to recognize content creators who are contributing meaningfully to financial literacy in India. As investor participation deepens, audiences are seeking clarity, context, and credibility. The response from creators was overwhelming and points to the new generation of financial educators.  As the inaugural winner Ms. Himani Chaudhary, exemplifies the standard of financial communication that Katalyst seeks to encourage.”

The first edition of the Kotak Alts Katalyst Awards received over six hundred entries from across 19 states and in 8 languages, reflecting the growing role of digital creators in shaping financial awareness. Conceived in response to increasing clutter and misinformation in the financial ecosystem, Katalyst is designed to recognize creators who place accuracy, transparency, and investor interest at the core of their work.

The winning content, ‘Personal Finance & Major Finance Updates’ by Himani Choudhary, was recognised for its clarity, originality, and credibility. The jury noted the content’s ability to explain complex financial concepts in a clear and measured manner, supported by strong research and a consistent focus on investor education over virality.

To ensure a robust and transparent evaluation process, the awards framework was designed and audited by EY. The top thirty entries were assessed by an academic jury.

The top 10 finalists were subsequently evaluated by a grand jury comprising Kunal Shah, Founder and CEO of CRED; Radhika Gupta, Managing Director and CEO of Edelweiss Mutual Fund; and Alpesh Shah, Managing Director and Senior Partner at Boston Consulting Group, and chaired by Ananth Narayan, former Whole–Time Member of SEBI with extensive capital markets and regulatory experience.

The Katalyst Awards recognise financial content creators who priorities financial literacy, substance, and long–term investor interest. Through this initiative, Kotak Alts aims to encourage responsible financial communication and support the development of informed and confident investors across India.

About Kotak Alternate Asset Managers Ltd: Kotak Alternate Asset Managers Limited (‘Kotak Alts’), a part of Kotak Mahindra Group (‘Kotak’), focuses on Alternate Asset Management and Investment Advisory businesses. Kotak Alts was set up in early 2005 and has raised, managed, and advised over USD 22 billion across different asset classes, including Private Equity, Real Estate, Infrastructure, Special Situations, Private Credit, and Investment Advisory. The asset management business and investment advisory vertical are managed by independent specialist teams. For more information, visit https://www.kotakalternateasset.com/

Image: https://oyefilmy.com/wp-content/uploads/2026/03/kotak-alts-announces-winner-of-the-inaugural-katalyst-awards-1.jpg

Cision View original content to download multimedia:https://www.prnewswire.com/in/news-releases/kotak-alts-announces-winner-of-the-inaugural-katalyst-awards-302709187.html

Continue Reading

News Wire

Paperpal for Life Sciences Establishes HIPAA Readiness, Strengthening Enterprise Adoption of AI in Regulated Medical and Scientific Writing Workflows

MUMBAI, India, March 10, 2026 /PRNewswire/ — Paperpal for Life Sciences, an enterprise-grade Artificial Intelligence (AI) platform by Cactus Communications, purpose-built for Medical Affairs and Life Sciences organizations, announced the completion of an assessment evaluating its operational and technical safeguards to support Health Insurance Portability and Accountability Act (HIPAA) requirements. This milestone reinforces Paperpal’s commitment to meeting the rigorous standards of security, data protection, and regulatory readiness required for regulated scientific workflows.

Growing AI use in medical affairs writing and publication workflows is intensifying scrutiny on data privacy, governance, and regulatory accountability. To support these evolving needs, Paperpal for Life Sciences has undertaken an assessment of its systems and processes to evaluate readiness to support HIPAA compliance, where applicable, and now proudly offers the option to execute a Business Associate Agreement (BAA) for Protected Health Information (PHI) and Personally Identifiable Information (PII). This offering gives customers the confidence that PHI or PII, if received, is handled securely and responsibly, in line with regulatory expectations and enterprise risk management practices.

Paperpal for Life Sciences provides AI writing, literature search, source-grounded summarization with citation support, and critical publication checks, powering medical affairs content creation under stringent data privacy and governance controls. The platform accelerates research-to-publication timelines by upto 25%, supporting faster dissemination of clinical evidence and earlier commercialization of new drugs and therapies.

Nishchay Shah, Group CTO and EVP, Products and AI at Cactus Communications, said, “As AI becomes foundational to regulated scientific and medical workflows, compliance and trust are no longer optional. Paperpal for Life Sciences’ HIPAA readiness measures reflect our secure-by-design approach to AI, strong data governance framework, and alignment with real-world enterprise and regulatory requirements. This milestone enables organizations to adopt AI at scale with confidence that their data, processes, and compliance obligations are protected .”

Elvira Dsouza, President, Cactus Life Sciences, added, “Medical Affairs and Life Sciences teams operate in highly regulated environments where scientific rigor, data privacy, and compliance are non-negotiable. HIPAA readiness positions Paperpal for Life Sciences as a trusted AI partner, one that enables organizations to accelerate evidence generation and scientific communication without compromising regulatory integrity .”

With this announcement, Paperpal for Life Sciences reinforces its position as a purpose-built, enterprise-ready AI platform for medical affairs content generation that supports innovation while meeting the highest standards of privacy, ethics, and regulatory compliance.

Media Contact:

Nidhi Amin

nidhi.amin@cactusglobal.com 

Logo: https://oyefilmy.com/wp-content/uploads/2026/03/paperpal-for-life-sciences-establishes-hipaa-readiness-strengthening-enterprise-adoption-of-ai-in-regulated-medical-and-scientific-writing-workflows-1.jpg

 

Cision View original content to download multimedia:https://www.prnewswire.com/in/news-releases/paperpal-for-life-sciences-establishes-hipaa-readiness-strengthening-enterprise-adoption-of-ai-in-regulated-medical-and-scientific-writing-workflows-302708082.html

Continue Reading

Trending